Bluejay Diagnostics, Inc.
BJDX Nasdaq
SEC CIK 1704287
Follow Bluejay Diagnostics
Weekly email: filings, results
Net income
−$2M
−25.9% vs same quarter last year
EPS, diluted
−$1.72
Operating cash flow
−$2M
−47.3% vs same quarter last year
Operating income
−$2.1M
−27.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$6.8M |
| FY24 | −$7.7M |
| FY23 | −$10M |
| FY22 | −$9.3M |
| FY21 | −$3.5M |
| FY20 | −$1.2M |
| FY19 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$6.2M |
| FY24 | −$8.1M |
| FY23 | −$9M |
| FY22 | −$8.9M |
| FY21 | −$4.4M |
| FY20 | - |
| FY19 | - |